(Q35019714)

5 August 2017

1 reference

title

The isoprostanes: their role as an index of oxidant stress status in human pulmonary disease (English)

1 reference

5 August 2017

Jason D Morrow

1

1 reference

5 August 2017

L Jackson Roberts

series ordinal

2

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 December 2002

1 reference

American Journal of Respiratory and Critical Care Medicine

5 August 2017

1 reference

5 August 2017

166

1 reference

5 August 2017

12 Pt 2

1 reference

5 August 2017

S25-30

1 reference

The measurement of free radical reactions in humans. Some thoughts for future experimentation

5 August 2017

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2206011

A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2206011

Noncyclooxygenase oxidative formation of a series of novel prostaglandins: analytical ramifications for measurement of eicosanoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2206011

A nomenclature system for the isoprostanes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2206011

The isoprostanes: a perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2206011

The isoprostanes: unique prostaglandin-like products of free-radical-initiated lipid peroxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2206011

Plasma levels of 8-epiPGF2alpha, an in vivo marker of oxidative stress, are not affected by aging or Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2206011

Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2206011

The isoprostanes: unique bioactive products of lipid peroxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2206011

Improved assay for the quantification of the major urinary metabolite of the isoprostane 15-F(2t)-Isoprostane (8-iso-PGF(2alpha)) by a stable isotope dilution mass spectrometric assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2206011

Formation of non-cyclooxygenase-derived prostanoids (F2-isoprostanes) in plasma and low density lipoprotein exposed to oxidative stress in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2206011

Generation of 8-epiprostaglandin F2alpha by human monocytes. Discriminate production by reactive oxygen species and prostaglandin endoperoxide synthase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2206011

A role for endothelial cell lipoxygenase in the oxidative modification of low density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2206011

Disruption of 12/15-lipoxygenase expression in peritoneal macrophages. Enhanced utilization of the 5-lipoxygenase pathway and diminished oxidation of low density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2206011

Absence of 12/15-lipoxygenase expression decreases lipid peroxidation and atherogenesis in apolipoprotein e-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2206011

Formation of novel non-cyclooxygenase-derived prostanoids (F2-isoprostanes) in carbon tetrachloride hepatotoxicity. An animal model of lipid peroxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2206011

Chronic obstructive pulmonary disease is associated with an increase in urinary levels of isoprostane F2alpha-III, an index of oxidant stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2206011

Exhaled 8-isoprostane as a new non-invasive biomarker of oxidative stress in cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2206011

Increased lipid peroxidation in patients with pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2206011

Assessment of oxidant stress in allergic asthma by measurement of the major urinary metabolite of F2-isoprostane, 15-F2t-IsoP (8-iso-PGF2alpha).

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2206011

Elevated plasma levels of F2 alpha isoprostane in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2206011

21 January 2018

Identifiers

DOI

10.1164/RCCM.2206011

1 reference

release_2qawrpghvvcude4zxj2s5lhyf4

5 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2qawrpghvvcude4zxj2s5lhyf4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference